NCT03000712已完成不适用
Single-center, Randomized, Open Label, Negative-controlled Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC(Autologous Adipose Tissue Derived Mesenchymal Stem Cells) After High Tibial Osteotomy Compared to Negative Control in the Osteoarthritis Patients.
R-Bio2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2016年11月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 26
- 试验地点
- 2
- 主要终点
- MRI scan
研究概览
简要总结
The purpose of this study is to evaluate the efficacy and safety of intra-articular injection of autologous adipose tissue derived mesenchymal stem cells compared after high tibial osteotomy to negative control in the osteoarthritis patients
详细描述
In this clinical trial, the investigational product is administered intra-articularly at 1 week after high tibial osteotomy in a patient with degenerative arthritis of the medial side.
The investigational product is autologous adipose-derived mesenchymal stem cells. As it does not use allogenic tissue and is incubated without additional genetic modification or mechanical and chemical modification through differentiation, it is classified as 'autologous cell therapy' and is completely free of immunologic rejection.
It primarily aims to regenerate cartilage, to improve pain and joint function. The intra-articular injection of the investigational product is expected to stimulate the regeneration and growth of cartilage, and to innovatively improve pain and joint function with cartilage regeneration compared to high tibial osteotomy alone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must consent in writing to participate in the study by signing and dating an informed consent document
- •Patients who can communicate (exclusion of anyone who cannot understand the questionnaire)
- •between 20 years and 80 years of age
- •Diagnosis of osteoarthritis by radiographic criteria of Kellgren and Lawrence grade 2-4
- •Diagnosis of osteoarthritis by ACR(American College of Rheumatology Criteria) Global functional criteria : There is the pain of the knee and radiographic osteophyte and at least one of the following (1) age >50 years (2) Less than 30 minutes of morning stiffness (3) The friction When moving weighted the knee
- •Patients who agree with contraception
- •Patients who agree to stop the existing osteoarthritis treatment and to get enough washout periods until medication time
- •Patients scheduled for High tibial osteotomy due to medial gonarthrosis
排除标准
- •patients with osteoporosis
- •Preparing for Pregnancy or Pregnant women or lactating mothers.
- •Patients with positive human immunodeficiency (HIV), hepatitis B (HBV), hepatitis C (HCV), venereal disease research laboratory(VDRL)
- •Patients with hypersensitivity to investigator product or investigational product component or those with a history
- •Patients who had participated in other clinical trials within 12 weeks prior to this study
- •Patients who received any drug by intra-articular injection for treatment within 2 months prior to this enrollment.
- •Patients who experienced as the knee joint cartilage and stem cell therapy or failure to treat
- •Patents who started or changed the physical therapy program established within 2 weeks before the start of the study or during the study(An established physical therapy program may continue for the duration of the trial, provided that it does not change in frequency and intensity)
- •Patents included in the following specific risk groups that may influence safety and efficacy assessments at the discretion of the investigator:: septic arthtritis, rheumatic disease, gout, recurrent pseudogout, paget disease, joint fracture, alcaptonuria, acromegaly, hemochromatosis, wilson's disease, primary osteochondrosis, hereditary disorder(ex: hyperkinesia), collagen gene abnormality ,etc
- •Patients who have clinically significant severe medical illnesses judged the principal investigator
- •Patients who have been diagnosed with malignancy within 5 years before screening (except for patients who were completely remissioned three years before screening criteria)
- •Patients who the principal investigator consider inappropriate for the clinical trial due to any other reasons
- •Patients who received concomitant contraindications and who have not passed the prescribed wash-out period before participating in the clinical trial
结局指标
主要结局
MRI scan
时间窗: 24 months
MRI perform to measure cartilage defect size change from baseline up to 27 weeks
次要结局
- WOMAC score(15, 27 weeks, 18, 24 months)
- PSQI(Pittsburgh Sleep Quality Index)(15, 27 weeks, 18, 24 months)
- EQ5D(15, 27 weeks, 18, 24 months)
- ROM(15, 27 weeks, 18, 24 months)
- KOOS (Knee Injury & Osteoarthritis Outcome Score)(15, 27 weeks, 18, 24 months)
- Incidence of adverse reactions and characteristics associated with investigational product(15, 27 weeks, 18, 24 months)
- MRI scan(15, 27 weeks, 18, 24 months)
- Kellgren & Lawrence grade(15, 27 weeks, 18, 24 months)
- PGIC(Patient Global Impression of Change)(15, 27 weeks, 18, 24 months)
- Biomarkers(15, 27 weeks, 18, 24 months)
- WOMAC sub-scale(15, 27 weeks, 18, 24 months)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
The efficacy and safety of intra-articular injections with the TNF-a antagonist infliximab in patients with chronic or recurrent arthritis of the knee.recurrent or persistent inflammatory arthritis involving a knee (rheumatoid arthritis, juvenile chronic arthritis, spondylarthropathies and arthritis of unknown origin) despite corticosteroid injections intra-articularNL-OMON24235department of rheumatologyLeids Universitair Medisch CentrumPostbus 9600 RC Leiden40
已完成
不适用
The efficacy and safety of intra-articular injections with the tumour-necrotising factor alpha (TNFa) antagonist infliximab in patients with chronic or recurrent arthritis of the kneeArthritis, spondyloarthropathy, rheumatoid arthritisMusculoskeletal DiseasesOther rheumatoid arthritisISRCTN17726268eiden University Medical Centre (LUMC) (The Netherlands)40
招募中
2 期
The effectiveness of Hyaluronic acid/Chondroitin injection on knee performance after surgical fixation.IRCT20170608034390N13Shahid Beheshti University of Medical Sciences32
已完成
不适用
Comparative Study of Safety and Efficacy of Two Hyaluronic Acids for the Treatment of Knee Osteoarthritis PainKnee OsteoarthritisNCT01295580Bioventus LLC349
已完成
2 期
Safety and efficacy of intra-articular injections of platelet-rich plasma for the treatment of osteoarthritis of the knee in the Japanese populatioOsteoarthritis of the kneeJPRN-UMIN000011829niversity of Tsukuba Hospital10